Study showed engineered stem cell-derived therapy recruits key immune cells and slows tumor growth, supporting continued ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...

McGill University-led research has discovered that transplanting gut microbiota from women with fibromyalgia into mice ...

World-first human clinical trials are underway for a Type One Diabetes drug, developed by Queensland researchers.

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

New research shows exercise could blunt alcohol’s damaging impact on the body, adding to evidence linking consumption to long ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

The influenza virus manipulates the body's gene regulation system to accelerate its own spread, according to researchers at ...

A consortium of researchers with multidisciplinary skills, coordinated by INRAE and including the CNRS, the Université ...

Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same arm.

Champions Oncology, Inc.’s CSBR share price has dipped by 5.57%, which has investors questioning if this is right time to buy ...